• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 20th May 2020

OHE Awarded Independent Research Organisation (IRO) Status by UKRI

OHE has been awarded the status of Independent Research Organisation (IRO) by Research Councils UK. This blog comments on the significance of this achievement. OHE is delighted to announce that we have been awarded  Independent Research Organisation (IRO) status. This has been…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

OHE has been awarded the status of Independent Research Organisation (IRO) by Research Councils UK. This blog comments on the significance of this achievement.

OHE is delighted to announce that we have been awarded  Independent Research Organisation (IRO) status. This has been granted by UK Research and Innovation (UKRI), which – through the seven Research Councils, Innovate UK and Research England – allocates more than £7 billion in research funding, primarily from the Science Budget of the Department for Business, Energy and Industrial Strategy (BEIS). IRO status is a recognition of OHE’s high quality of independent research, and places us on equal footing with the UK’s Higher Education Institutions, making us eligible to apply for UKRI funding on the same terms.

The application process for IRO status is a long and challenging one. For OHE, this has taken three years of hard work and plenty of form filling (see here for the requirements)! In obtaining IRO status, OHE joins a highly selective list of organisations conducting research in health economics (and related areas), namely: the Institute for Fiscal Studies (IFS); the National Centre for Social Research (NatCen); the National Institute of Economic and Social Research (NIESR); Nesta; the Overseas Development Institute (ODI); Rand Europe; and the Wellcome Trust Sanger Institute. Across the UK, there are only 63 IROs in total across all research fields, including areas as diverse as medicine, defence studies, history, and oceanography. 

Professor Graham Cookson, OHE’s Chief Executive: We are all rightly proud of this achievement that puts OHE on an equal footing with the UK’s research heavy weights – from the University of Oxford to the Wellcome Trust – and recognises our important contribution to research on the economics of health and health care globally. The current global pandemic reinforces the need for scientifically robust, evidence-based policymaking and OHE will continue to contribute to delivering valuable insights and improving decision making.

Founded in 1962 by the ABPI, OHE is the world’s oldest health economics research centre. For nearly 60 years, OHE has produced world-leading insights on the health and life sciences sectors, and is considered a pioneer across a number of fields including the regulation of pharmaceutical pricing and the reimbursement of pharmaceutical product value, but is best known for its extensive work on the opportunity cost of health care investments. Becoming a charity in 2016 was a significant milestone on OHE’s journey towards greater independence and global prominence, and the quality and independence of our research has now been officially recognised by the UK government. Our research has been published in the most prestigious scientific journals including among others Journal of Health Economics, Health Economics, The Lancet, Value in Health, Social Science and Medicine, and Plos One. We attract funding from major research institutions including the Health Foundation, National Institute for Health Research, Cancer Research UK, the Bill & Melinda Gates Foundation and the Wellcome Trust. In 2019 alone, OHE was awarded 8 new research projects with a combined value of £580k. Also in 2019, OHE published 23 papers in peer reviewed journals,13 externally reviewed OHE working papers, and held 5 lunchtime seminars on a variety of health policy research subjects.

Professor Mike Drummond, Chair of OHE’s Board of Trustees: The granting of IRO status is further external recognition of the quality and excellence of OHE’s research programme. Although the reputation of OHE within the health services research community has been high for some time, it is a pleasure to see that this is now recognised more widely. OHE’s independent Research Committee, which I Chair on behalf of the Trustees, will continue to work with OHE’s researchers to ensure that their work is of high quality and high relevance to health care in the UK and overseas.

Professor Mireia Jofre-Bonet, OHE’s Head of Research: Achieving the status of Independent Research Organisation is the culmination of a long administrative process, but critically it recognises and rewards years of dedicated research and hard work by a team of world-leading academics at OHE past and present. It certifies the independence of our research and widens OHE’s access to future funding.

 

  • Research
  • Spotlight on OHE

Related News

  • News
  • November 2021

Opportunity Cost in Health Care: a Favourite Research Topic for OHE

Read more
  • News
  • February 2019

OHE Response to Public Consultation on NICE Principles

Read more
  • News
  • December 2018

OHE Achievements in 2018

Read more
screenshot
  • News
  • May 2018

A New Online Tool for Creating Personal and Social EQ-5D-5L Value Sets

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!